Cyclo‐oxygenase‐2 expression in photon‐radiated and non‐radiated uveal melanomas |
| |
| Authors: | Daniela Suesskind Frank Paulsen Markus Buchgeister Bernhard Spitzer Jens M. Rohrbach Karl U. Bartz‐Schmidt Martin S. Spitzer |
| |
| Affiliation: | 1. University Eye Hospital, Centre for Ophthalmology, Eberhard‐Karls University of Tuebingen, Germany;2. Department for Radiation Oncology, Eberhard‐Karls University of Tuebingen, Germany;3. Bernstein Centre for Computational Neuroscience, Charité, Berlin, Germany |
| |
| Abstract: | Purpose: To determine and compare cyclo‐oxygenase‐2 (COX‐2) expression in photon‐radiated and non‐radiated malignant uveal melanomas and to analyse the correlation between COX‐2 expression and prognosis. Methods: Immunohistochemical staining for COX‐2 was performed on 21 uveal melanomas that were endoresected after prior stereotactic radiotherapy with photons and on 22 tumours that were treated by endoresection without prior radiotherapy. COX‐2 staining was further analysed in respect to cell type, maximal prominence, time interval between radiotherapy and surgery, apoptotic index (AI), proliferative index (PI) and the development of metastatic disease. Results: There was no difference in COX‐2 expression between radiated and non‐radiated melanomas (P > 0.15). COX‐2 staining correlated with neither the tumour prominence (P > 0.40) nor the AI or the PI (both P > 0.35). Tumours with high COX‐2 expression were significantly more likely to develop metastasis (P = 0.022). Conclusion: Radiotherapy with photons does not induce COX‐2 expression in malignant melanomas of the uvea. But high COX‐2 expression may be a marker for poor prognosis. |
| |
| Keywords: | adjuvant therapy cyclo‐oxygenase‐2 radiotherapy uveal melanoma |
|
|
